NCIt definition : An orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with
potential antineoplastic activity. fexagratinib binds to and inhibits FGFR, which
may result in the inhibition of FGFR-related signal transduction pathways, and, so,
the inhibition of tumor cell proliferation and tumor cell death. FGFR, up-regulated
in many tumor cell types, is a receptor tyrosine kinase essential to tumor cellular
proliferation, differentiation and survival.;
UNII : 2167OG1EKJ;
CAS number : 1035270-39-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1035270-39-3
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;